Dr. William Gueck reports aggregated 5% stake in Mesoblast via ADR holdings
Rhea-AI Filing Summary
Dr. William Gueck reported beneficial ownership of 64,521,900 Ordinary Shares of Mesoblast Ltd held in the form of American Depositary Receipts (ADRs), representing approximately 5.0% of the company's outstanding Ordinary Shares based on 1,281,167,187 shares outstanding. He is the sole beneficial owner of 525,000 ADRs and reports discretionary authority over additional ADRs held by family members, trusts and entities, including 49,717,450 ADRs held by Cova Holdings LP, 350,000 ADRs underlying exercisable warrants held by Cova Holdings LP, and 8,345,150 ADRs held by AVCO Holdings LP. The filing disclaims admission of beneficial ownership of shares held by the identified entities.
Positive
- Clear disclosure of aggregated beneficial ownership totaling 64,521,900 ADR-form Ordinary Shares (~5.0% of outstanding shares)
- Transparency on composition of holdings, showing direct ownership and discretionary authority over family, trust and entity positions including Cova Holdings LP and AVCO Holdings LP
Negative
- None.
Insights
TL;DR: Disclosure notifies the market that an individual may control roughly 5% of Mesoblast via ADRs and related entities, a material ownership stake.
This Schedule 13G reports aggregated beneficial ownership of 64,521,900 ADR-form Ordinary Shares, about 5.0% of issued shares. The filing clarifies direct ownership (525,000 ADRs) and extensive discretionary control over ADRs held by family members, trusts and two holding entities, including a large position at Cova Holdings LP. For investors and market participants, the filing increases transparency about concentration of holdings and potential voting influence without asserting an intent to change control.
TL;DR: The disclosure highlights governance relevance due to consolidated voting/dispositive authority across related parties and entities.
The report details discretionary voting and disposition authority over multiple accounts and vehicles, which is important for governance analysis because it aggregates influence beyond the Reporting Person's sole holdings. The explicit disclaimer regarding beneficial ownership of entity-held shares is standard, but the aggregation disclosed here should prompt stakeholders to note where voting power may be concentrated.
FAQ
What stake in Mesoblast (MEOBF) does Dr. William Gueck report?
Which entities' holdings are included in the reported total?
AI-generated analysis. How Rhea-AI works. Not financial advice.